Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 5 months ago
Share
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
10000 patients around the world
Available in
Spain, Argentina
Novo Nordisk A/S
10000
Patients around the world
This study is for people with
Coronary heart disease
Acute myocardial infarction
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
See details
Contact us
Contact us
Study
ARTEMIS
Sponsor
Novo Nordisk A/S
Conditions
Acute myocardial infarction
Requirements
From 18 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT06118281
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent